Keywords: ADPKD; RCC; agenesis;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Pulmonary cysts; Bronchiectasis; ADPKD;
Keywords: ADPKD; chronic kidney disease; glomerular filtration rate;
Keywords: ADPKD; autosomal dominant polycystic kidney disease; LTx; liver transplantation; HVE; hepatic vascular exclusion; MELD; model for end-stage liver disease; PLD; polycystic liver disease; TVI; total vascular isolation; UCLA; University of California Los Ang
Keywords: Polycystic kidney; autosomal dominant; kidney diseases; cystic; ADPKD; pain; patient-reported outcome (PRO); patient-centered outcomes; quality of life (QoL); PRO instrument; disease burden;
Keywords: ADPKD; cardiovascular disease; intracranial aneurysms; cost-utility analysis;
Keywords: ADPKD; beta-2 microglobulin; kidney function decline; kidney volume; MCP-1; urinary biomarkers;
Keywords: α-CGRP; alpha-calcitonin gene related peptide; Ang; angiopoietin; AE2; anion exchanger 2; ADP; adenosine diphosphate; ADPKD; autosomal dominant polycystic kidney disease; ATP; adenosine triphosphate; ASBT; sodium-dependent bile acid transporter; AQP; aqu
Keywords: AAV; adeno-associated virus; ADPLD; autosomal dominant polycystic liver disease; ADPKD; autosomal dominant polycystic kidney disease; CNN; copy-number neutral; CRISPR/Cas9; clustered regulatory interspaced short palindromic repeats associated RNA-guided C
Keywords: PC1; polycystin-1; PC2; polycystin-2; ADPKD; autosomal dominant polycystic kidney disease; PKD1; PC1 gene; PKD2; PC2 gene; ESRD; end stage renal disease; Ca2+; calcium; cAMP; cyclic adenosine monophosphate; MAPK; mitogen-activated protein kinase; mTOR; me
Keywords: ADPKD; Autosomal Dominant Polycystic Kidney Disease; UPJ; congenital ureteropelvic junction obstruction; HK; horseshoe kidney; RCC; renal cell carcinoma; MVA; motor vehicle accident; PVA; pedestrian vehicle accident; GH; gross haematuria; AP; abdominal pa
Keywords: Polycystic kidney disease; Renal nutrition; Net acid excretion; Potential renal acid load; Dietary acid load; Net endogenous acid production; ADPKD; autosomal dominant polycystic kidney disease; AI; adequate intake; AMDR; acceptable macronutrient dietary
Keywords: ADPKD; celiac plexus block; major splanchnic nerve block; pain; polycystic kidney disease; renal denervation;
Keywords: ADPKD; BCAA; LAT-1; mTOR;
Keywords: ADPKD; cardiomyopathies; hypertrophic cardiomyopathy; idiopathic dilated cardiomyopathy; left ventricular noncompaction; polycystic kidney;
Keywords: AA; activin A; ADPKD; autosomal dominant polycystic kidney disease; AKI; acute kidney injury; AQP; aquaporin; ARPKD; autosomal recessive polycystic kidney disease; BMP; bone morphogenetic protein; CD; collecting duct; CDH1/ECAD; cadherin 1/E-cadherin; CDH
Keywords: ADPKD; Autosomal Dominant Polycystic Kidney Disease; SI; signal intensity; PKD1; Polycystic Kidney Disease 1 Gene; PKD2; Polycystic Kidney Disease 2 Gene; MRI; Magnetic Resonance Imaging; SSFSE; Single Shot Fast Spin Echo; LAVA; liver accelerated volume a
Keywords: PKD; polycystic kidney disease; ADPKD; autosomal dominant polycystic kidney disease; ARPKD; autosomal recessive polycystic kidney disease; DHPLC; denaturing high performance liquid chromatography; SSCP; single strand polymorphism analysis; PGD; preimplant
Keywords: kidney calculi; osmolar concentration; vasopressins; water-electrolyte balance; ADPKD; autosomal dominant polycystic kidney disease; AVP; arginine vasopressin; CaOx; calcium oxalate; CaP; calcium phosphate; SS; supersaturation; UA; uric acid;
Keywords: ADPKD; autosomal dominant polycystic kidney disease; ADPLD; autosomal dominant polycystic liver disease; AP; alkaline phosphatase; ALT; alanine aminotransaminase; AST; aspartate aminotransaminase; Ca2+i; intracellular calcium; cAMP; cyclic adenosine monop
Keywords: ADPKD; autosomal dominant polycystic kidney disease; IQR; interquartile range; LV; liver volume; LV1; preoperative liver volume; LV2; postoperative liver volume; LV3; liver volume at follow-up; MELD; Model for End-Stage Liver Disease; PHCF; partial hepate
Keywords: ADPKD Volume; Cyst Growth; Somatostatin Analogue; ADPKD; adult polycystic kidney disease; ALADIN; A Long-acting Somatostatin Analogue on Disease Progression in Nephropathy due to Autosomal Dominant Polycystic Kidney Disease; cAMP; cyclic adenosine monopho
Keywords: ADPKD; autosomal dominant polycystic kidney disease; ALADIN; Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study; CRISP; Consortium for Radiologic Imaging Studies in Polycystic Kidney Disease; CT; computed tomography; eGFR; estimated
Keywords: ADPKD; autosomal dominant polycystic kidney disease; ADPLD; autosomal dominant polycystic liver disease; AKT; v-akt murine thymoma viral oncogene homolog 1; ALP; alkaline phosphatase; α-Sma; alpha-smooth muscle actin; ALT; alanine aminotransferase; ARPKD
Keywords: ADPKD; PKD1; PKD2; polycystin-1; polycystin-2; TRPP2;
Keywords: HALT-PKD-A; Hepatic Cyst; CKD; MRI Analysis; ADPKD; autosomal-dominant polycystic kidney disease; ALP; alkaline phosphatase; ALT; alanine aminotransferase; BMI; body mass index; BP; blood pressure; BSA(m2); body surface area (corrected for height); eGFR;
Keywords: ADPKD; integrin-linked kinase; integrins; osteoblast-specific factor 2; proliferation;
Keywords: ADPKD; calcium; cyclic AMP; ion channel; polycystic kidney disease; renal tubular epithelial cells;
Keywords: Polycystic kidney; ARPKD; ADPKD; Multicystic dysplastic kidney; Renal cyst;
Keywords: cAMP; cyclic adenosine monophosphate; mTOR; mammalian target of rapamycin; EGFR; epidermal growth factor receptor; ERK; extracellular-signal-regulated kinases; ADPKD; Berberine; Cell proliferation; ERK and p70-S6 signaling; Apoptosis;
Keywords: ADPKD; autosomal dominant polycystic kidney disease; CT; computed tomography; ESRD; end-stage renal disease; LR-PCR; long-range polymerase chain reaction; MRI; magnetic resonance imaging; ORF; open reading frame; targeted DNA-HiSeq; targeted gene and next
Bladder diverticuli following injection of onabotulinum toxin A in a patient with multiple sclerosis and autosomal dominant polycystic kidney disease
Keywords: Bladder diverticuli; Onabotulinum toxin A; Botox; ADPKD; multiple sclerosis; MRI;
REPRISE: tolvaptan in advanced polycystic kidney disease
Keywords: ADPKD; chronic kidney disease; vasopressin;
Proteomic analysis of AQP11-null kidney: Proximal tubular type polycystic kidney disease
Keywords: ADPKD; Proximal tubule; AQP11; Proteome; Reg1;
Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene
Keywords: ADPKD; Autosomal Dominant Polycystic Kidney Disease; ESRD; end-stage renal disease; Leucine-rich LRR; leucine rich repeat; WSC; cell wall integrity and stress response component; LDL-A; low density lipoprotein-A; IG-Like; immunoglobulin-like; REJ; recepto
Polycystin-1 downregulation induces ERK-dependent mTOR pathway activation in a cellular model of psoriasis
Keywords: ADPKD; autosomal polycystic kidney disease; ERK; extracellular signal-regulated kinases; MAPK; mitogen-activated protein kinases; mTOR; mammalian target of rapamycin; PC1; polycystin-1; PC2; polycystin-2; Polycystin; Psoriasis; mTOR; Mechanotransduction;
NOS3 gene Glu298Asp polymorphism and severity of disease in patients of ADPKD from North India
Keywords: ADPKD; End stage renal disease (ERSD); Hypertension; NOS3 gene polymorphism; PKD1 gene;
Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy
Keywords: Tuberous sclerosis; Autosomal dominant polycystic kidney disease; ADPKD; Angiomyolipoma; mTOR inhibitors; Contiguous gene syndrome; TSC2/PKD1; Esclerosis tuberosa; Poliquistosis renal autosómica dominante; PQRAD; Angiomiolipoma; Inhibidores de mTOR; SÃn
Clinical and laboratory observationsImprovement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor
Keywords: tuberous sclerosis complex; subependymal giant cell astrocytoma; autosomal dominant polycystic kidney disease; contiguous gene syndrome; case series; ADPKD; Autosomal dominant polycystic kidney disease; CGS; Contiguous gene syndrome; MRI; Magnetic resonan
Polykystose rénale : analyse des discussions des e-patients sur la blogosphère publique
Keywords: Association de patients; Internet; Patient; PKD; PKRAD; Polykystose rénale; ADPKD; Internet; Patient; Patient association group; PKD; Polycytic kidney disease;
TRPP2 ion channels: Critical regulators of organ morphogenesis in health and disease
Keywords: TRP channels; TRPP2; Morphogenesis; ADPKD; Cilia;
Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease
Keywords: ADPKD; apoptosis; signaling;
STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease
Keywords: ADPKD; cell signaling; cell survival; gene expression;
B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease
Keywords: adeno-associated virus; ADPKD; ARPKD; congenital hepatic fibrosis; gene therapy;
Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation
Keywords: ADPKD; Ganoderma lucidum; kidney; MDCK; Ras/MAPK;
Profiling conserved biological pathways in Autosomal Dominant Polycystic Kidney Disorder (ADPKD) to elucidate key transcriptomic alterations regulating cystogenesis: A cross-species meta-analysis approach
Keywords: ADPKD; Autosomal Dominant Polycystic Kidney disease; GEO; Gene Expression Omnibus; PC1; polycystin-1; PC2; polycystin-2; DEGs; differentially expressed genes; BH; Benjamini & Hochberg; GO; Gene Ontology; GO BP; GO Biological Processes; PANTHER; Protein AN
Evaluation of [18F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease
Keywords: Para-[18F]fluorohippurate; PET; Renography; ADPKD; Prognostic biomarker;
ECE1 gene variant shows tendency toward chronic kidney disease advancement among autosomal polycystic kidney disease patients
Keywords: ADPKD; CKD; ECE1 gene; hypertension
Mutations in DCDC2 (doublecortin domain containing protein 2) in neonatal sclerosing cholangitis
Keywords: ADPKD; autosomal dominant polycystic kidney disease; ARPKD; autosomal recessive polycystic kidney disease; ACALT; acetylated alpha-tubulin; BA; biliary atresia; Ca2+; calcium; CHF; congenital hepatic fibrosis; DCDC2; doublecortin domain containing protein
Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease
Keywords: Polycystic kidney disease; Autosomal Dominant Polycystic Kidney Disease; Pkd1; ADPKD; Mouse model; Systems biology; Metabolism; Fatty acid oxidation; Fatty acid oxidation defect; Lipid metabolism; Diet